# The Killing Antidote

> ResidualPlay case file: an overlooked Steam game still earning residual revenue. Estimates carry a ±30-50% error range per title.

- Steam appid: 2254890
- Developer: MetalStar Studio
- Released: 2024 · Genre: Action · List price: $29.99
- Deal grade: C (A = dormant with >=$5k/mo opportunity, D = low signal)
- Est. net residual revenue: $27.8k to $41.8k per month (mid $34.8k)
- Opportunity score: $34.8k/month at x1.00 dormancy multiplier
- Est. lifetime owners: 236.8k · Est. lifetime net revenue: $2.1M
- Review sentiment: 89% positive across 7722 reviews (7401 from Steam purchases)
- Review velocity: 158.8 reviews/month (6-month average)

## Why it's flagged

- Developer active, last post 5 months ago
- Last build shipped 4 months ago

## Where a gross dollar goes (monthly, at current velocity)

| Stage | USD/month |
|---|---|
| Gross storefront sales | $63.2k |
| After VAT / sales tax (-13% blended) | $55.0k |
| After refunds (-9.5% median) | $49.8k |
| Net to developer (after Steam 30%) | $34.8k |

## Monthly review counts, oldest to newest (22 months)

1783, 516, 566, 358, 431, 410, 248, 268, 276, 193, 242, 153, 138, 705, 256, 184, 204, 207, 125, 169, 123, 125

## Markets by review language

- german: 2%
- koreana: 3%
- russian: 12%
- spanish: 4%
- japanese: 1%
- schinese: 39%
- french: 2%
- english: 33%
- brazilian: 4%

## Methodology

Units are estimated from Steam-purchase reviews times a release-cohort multiplier (Boxleiter method, 20-75x by year). Revenue uses an effective price (lifetime discounts and regional pricing) and nets out VAT (~13%), refunds (~9.5%) and Steam's 30% cut: roughly 55% of gross reaches the developer.

Source: https://residualplay.com/game/2254890
Citation: please cite ResidualPlay (https://residualplay.com) when using these estimates.